Actus des entreprises
Roquette Receives "Biopharma Innovation of the Year" Award 2024
Roquette is proud to announce that they have been honored with the "Biopharma Innovation of the Year" award for 2024 at Biologics Manufacturing Korea and Vaccine World East Asia Congress 2024. This prestigious accolade recognizes their leading-edge work and our commitment to advancing pharmaceutical innovation with their KLEPTOSE® Biopharma hydroxypropyl beta-cyclodextrin solution.
A Landmark Achievement
This award is a significant achievement for Roquette, reflecting their dedication to innovation and the impact of their solutions on the biopharma industry. Vinod Tuliani, VP & Head of Global Pharmaceutical Sciences, commented on the award: “Winning this award is a tremendous honor for Roquette. It highlights our commitment to pushing the boundaries of pharmaceutical innovation and showcases the success of our KLEPTOSE® Biopharma solution. This recognition underscores the expertise of our team and inspires us to continue advancing our solutions to meet the evolving needs of the industry.”
KLEPTOSE® Biopharma: A Game-Changer in the Industry
KLEPTOSE® Biopharma has been instrumental in overcoming critical challenges faced by biopharmaceutical companies. Its advanced formulation enhances protein recovery, reduces particle formation, and stabilizes antibodies during formulation. Notably, KLEPTOSE® Biopharma offers superior stability compared to other products, effectively addresses subvisible particle formation, and provides viscosity reduction for highly concentrated monoclonal antibodies (mAbs). Its effectiveness in reducing aggregation in antibody-drug conjugates (ADCs) and its wide application in vaccine development make it a vital tool for the biopharma sector.
Future Priorities
This recognition reaffirms their commitment to innovation and excellence. Their future priorities include:
- Driving Innovation: Continuously developing advanced pharmaceutical excipients and drug delivery systems.
- Advancing Sustainability: Committing to sustainable practices and reducing their environmental footprint.
- Strengthening Collaborations: Expanding partnerships with biopharma companies and research institutions.
- Expanding Global Reach: Enhancing their presence in emerging markets to serve a diverse global client base.
They extend their sincere thanks to the biopharma community for their support and recognition. This award motivates them to continue pushing the boundaries of pharmaceutical innovation and to collaborate on achieving new milestones.
SOURCE : ROQUETTE
